Celgene launch new UK and Ireland office
On Monday 21st November 2011, Liftstream’s MD – Karl Simpson, attended the official launch of Celgene’s new UK & Ireland office at Stockley Park. Hosted by Celgene’s Sam Pearce, General Manager...
View ArticleSoriot to apply therapy to AstraZeneca
On 26th of April 2012 David Brennan stepped down as AstraZeneca’s CEO after 6 years in the job. David Brennan had risen through the ranks at AstraZeneca first at Astra and later after the merger with...
View ArticleGenesis 2012 – The Debate on UK Biotech
Authored by Karl Simpson The One Nucleus event hosted the annual conference and this year it rounded off with a debate. On the one side were the ‘Enablers’ and on the other was ‘Industry’, chaired...
View ArticleGSK Expands Vaccines Capabilities with Okairos Purchase
Authored by James Sheppard The vaccines field has been hoting up recently with a number of companies on the march in the area. In the past 5 years over 190 vaccine partnering deals have been initiated...
View ArticleProsensa, Sarepta, PTC, Summit and DART all contribute to the ubiquity of...
Authored by James Sheppard The Duchenne Muscular Dystrophy market has seen considerable advances in recent months, with companies Prosensa, PTC Therapeutics, Sarepta Therapeutics, Summit and...
View ArticleAnaptysBio expands its cancer immunotherapy portfolio
Authored by Karl Simpson Anti-PD1 Antibody combined with TIM-3 and LAG-3 antagonists Cancer Immunotherapy is an area that is gaining increasing levels of interest across the cancer therapeutics...
View ArticleUK aiming to boost regenerative medicine
Authored by James Sheppard Three of the UK’s leading research councils have pledged £25m to help kick start the regenerative medicine field in the UK. The funding will be used to provide equipment and...
View ArticleAstraZeneca makes play in ADC market
Authored by James Sheppard Global pharmaceutical giant AstraZeneca has recently announced the acquisition of UK based antibody-drug conjugate (ADC) specialist Spirogen. The deal will put Spirogen as...
View ArticleUK Government names biotech veteran Minister for Life Sciences
Authored by James Sheppard The UK government has announced it has created a new role of Minister for Life Sciences to which it has appointed former biotech venture capitalist George Freeman. Mr Freeman...
View ArticleWomen Currently only 10% of Biotech Boards, Gender Study Shows
Authored by Karl Simpson In a new research study into gender diversity in biotech leadership, the findings convey a picture of significant male dominance in biotech boardroom. The research conducted by...
View ArticleMereo BioPharma forms with Novartis assets and Institutional Investment
A new UK company focused on acquiring, rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health Highly experienced management team; blue...
View ArticleGenentech ex-CEO added to Agios Board of Directors
Agios Pharmaceuticals, Inc. based in Cambridge, Massachusetts, a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the appointment of Ian Clark to its...
View Article